Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
12.30
+0.24 (1.99%)
Nov 18, 2026, 12:30 PM EST - Market open
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $891.8 million as of November 18, 2026. Its market cap has decreased by 19.38% in one year.
Market Cap
891.80M
Enterprise Value
819.00M
1-Year Change
-19.38%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $891.80M, an increase of 592.10%. That is a compound annual growth rate of 7.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 891.80M | -22.26% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 925.69M |
| Odyssey Therapeutics | 915.67M |
| Corvus Pharmaceuticals | 898.36M |
| MeiraGTx Holdings | 889.35M |
| Inventiva | 876.69M |
| City Therapeutics | 862.78M |
| Immatics | 859.78M |
| Latigo Biotherapeutics | 853.94M |